4.6 Article

Clinical validation of an array CGH test for HER2 status in breast cancer reveals that polysomy 17 is a rare event

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Oncology

Polysomy 17 in Breast Cancer: Clinicopathologic Significance and Impact on HER-2 Testing

Isabelle Vanden Bempt et al.

JOURNAL OF CLINICAL ONCOLOGY (2008)

Article Medicine, Research & Experimental

Genomic analysis of the HER2/TOP2A amplicon in breast cancer and breast cancer cell lines

Edurne Arriola et al.

LABORATORY INVESTIGATION (2008)

Article Biochemistry & Molecular Biology

Characterization of breast cancer by array comparative genomic hybridization

J. Climent et al.

BIOCHEMISTRY AND CELL BIOLOGY (2007)

Review Pathology

Application of array-based comparative genomic hybridization to clinical diagnostics

Bassem A. Bejjani et al.

JOURNAL OF MOLECULAR DIAGNOSTICS (2006)

Review Oncology

Array-CGH and breast cancer

Erik H. van Beers et al.

BREAST CANCER RESEARCH (2006)

Article Multidisciplinary Sciences

Automated array-based genomic profiling in chronic lymphocytic leukemia:: Development of a clinical tool and discovery of recurrent genomic alterations

C Schwaenen et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)

Article Oncology

Profiling breast cancer by array CGH

DG Albertson

BREAST CANCER RESEARCH AND TREATMENT (2003)

Article Oncology

Chromosome 17 aneusomy is associated with poor prognostic factors in invasive breast carcinoma

AD Watters et al.

BREAST CANCER RESEARCH AND TREATMENT (2003)

Article Oncology

Real-world performance of HER2 testing - National surgical adjuvant breast and bowel project experience

S Paik et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)

Article Oncology

Concordance between local and central laboratory HER2 testing in the breast intergroup trial N9831

PC Roche et al.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)